Compare · AMED vs OPCH
AMED vs OPCH
Side-by-side comparison of Amedisys Inc (AMED) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMED and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- AMED is the larger of the two at $4.20B, about 1.3x OPCH ($3.22B).
- Over the past year, AMED is up 7.1% and OPCH is down 35.3% - AMED leads by 42.4 points.
- OPCH has hit the wire 12 times in the past 4 weeks while AMED has been quiet.
- AMED has more recent analyst coverage (25 ratings vs 14 for OPCH).
- Company
- Amedisys Inc
- Option Care Health Inc.
- Price
- $100.98-0.00%
- $20.48+2.02%
- Market cap
- $4.20B
- $3.22B
- 1M return
- +3.66%
- +0.17%
- 1Y return
- +7.08%
- -35.33%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 0
- 12
- Recent ratings
- 25
- 14
Amedisys Inc
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. As of December 31, 2020, the company owned and operated 320 home health care centers, 180 hospice care centers, and 14 personal-care care centers in 39 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest AMED
- SEC Form 15-12G filed by Amedisys Inc
- Twilio Set to Join S&P MidCap 400
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
Latest OPCH
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)
- Director Brandt Eric was granted 11,640 shares, increasing direct ownership by 112% to 21,999 units (SEC Form 4)